...
search icon
xlo-img

Xilio Development Inc Share Price

XLO
NAQ
$0.5802
-$0.02
(-3.35%)
1D
Industry: Biotechnology Sector: Health Care

Xilio Development Inc Analyst Forecast

Xilio Development Inc Share Price Chart

Xilio Development Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$40.27M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
333.23K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.04
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.5 L
$1.3 H
$0.5802

About Xilio Development Inc, Common Stock

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Xilio Development Inc Stock Returns

Time FrameXLOSectorS&P500
1-Week Return7.25%-1.08%-1.38%
1-Month Return-11.55%-0.47%-1.81%
3-Month Return-17.35%2.13%1.38%
6-Month Return-18.85%17.04%5.68%
1-Year Return-55.02%6.56%11.74%
3-Year Return-80.46%16.78%65.15%
5-Year Return-96.37%34.34%73.68%

Xilio Development Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue----6.34M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue1.06M1.50M1.85M1.90M1.64M[{"date":"2020-12-31","value":56.05,"profit":true},{"date":"2021-12-31","value":78.89,"profit":true},{"date":"2022-12-31","value":97.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.53,"profit":true}]
Gross Profit(1.06M)(1.50M)(1.85M)(1.90M)6.34M[{"date":"2020-12-31","value":-16.79,"profit":false},{"date":"2021-12-31","value":-23.63,"profit":false},{"date":"2022-12-31","value":-29.11,"profit":false},{"date":"2023-12-31","value":-29.95,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin----100.00%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses53.50M75.04M89.15M79.13M66.93M[{"date":"2020-12-31","value":60.01,"profit":true},{"date":"2021-12-31","value":84.18,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.76,"profit":true},{"date":"2024-12-31","value":75.07,"profit":true}]
Operating Income(54.56M)(75.04M)(89.15M)(79.13M)(60.58M)[{"date":"2020-12-31","value":-5456300000,"profit":false},{"date":"2021-12-31","value":-7504400000,"profit":false},{"date":"2022-12-31","value":-8914900000,"profit":false},{"date":"2023-12-31","value":-7913300000,"profit":false},{"date":"2024-12-31","value":-6058200000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(55.22M)(75.80M)(88.22M)(76.40M)(58.24M)[{"date":"2020-12-31","value":-5521900000,"profit":false},{"date":"2021-12-31","value":-7580000000,"profit":false},{"date":"2022-12-31","value":-8822200000,"profit":false},{"date":"2023-12-31","value":-7640400000,"profit":false},{"date":"2024-12-31","value":-5824100000,"profit":false}]
Income Taxes858.70K(1.50M)(927.00K)(927.00K)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-174.57,"profit":false},{"date":"2022-12-31","value":-107.95,"profit":false},{"date":"2023-12-31","value":-107.95,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(55.22M)(75.80M)(88.22M)(81.22M)(58.24M)[{"date":"2020-12-31","value":-5521900000,"profit":false},{"date":"2021-12-31","value":-7580000000,"profit":false},{"date":"2022-12-31","value":-8822200000,"profit":false},{"date":"2023-12-31","value":-8121500000,"profit":false},{"date":"2024-12-31","value":-5824100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(55.22M)(74.30M)(87.30M)(76.40M)(58.24M)[{"date":"2020-12-31","value":-5521900000,"profit":false},{"date":"2021-12-31","value":-7430100000,"profit":false},{"date":"2022-12-31","value":-8729500000,"profit":false},{"date":"2023-12-31","value":-7640400000,"profit":false},{"date":"2024-12-31","value":-5824100000,"profit":false}]
EPS (Diluted)(107.37)(25.16)(3.22)(2.78)(1.28)[{"date":"2020-12-31","value":-10736.77,"profit":false},{"date":"2021-12-31","value":-2516,"profit":false},{"date":"2022-12-31","value":-322,"profit":false},{"date":"2023-12-31","value":-278,"profit":false},{"date":"2024-12-31","value":-128,"profit":false}]

Xilio Development Inc Ratios

Xilio Development Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

XLO
Cash Ratio 1.84
Current Ratio 2.20

Xilio Development Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

XLO
ROA (LTM) -26.26%
ROE (LTM) -908.28%

Xilio Development Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

XLO
Debt Ratio Lower is generally better. Negative is bad. 1.06
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.06

Xilio Development Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

XLO
Trailing PE NM
Forward PE NM
P/S (TTM) 1.27
P/B 5.87
Price/FCF NM
EV/R 1.95
EV/Ebitda NM

FAQs

What is Xilio Development Inc share price today?

Xilio Development Inc (XLO) share price today is $0.5802

Can Indians buy Xilio Development Inc shares?

Yes, Indians can buy shares of Xilio Development Inc (XLO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in XLO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Xilio Development Inc be purchased?

Yes, you can purchase fractional shares of Xilio Development Inc (XLO) via the Vested app. You can start investing in Xilio Development Inc (XLO) with a minimum investment of $1.

How to invest in Xilio Development Inc shares from India?

You can invest in shares of Xilio Development Inc (XLO) via Vested in three simple steps:

  • Click on Sign Up or Invest in XLO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Xilio Development Inc shares
What is Xilio Development Inc 52-week high and low stock price?

The 52-week high price of Xilio Development Inc (XLO) is $1.3. The 52-week low price of Xilio Development Inc (XLO) is $0.5.

What is Xilio Development Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Xilio Development Inc (XLO) is

What is Xilio Development Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Xilio Development Inc (XLO) is 5.87

What is Xilio Development Inc dividend yield?

The dividend yield of Xilio Development Inc (XLO) is 0.00%

What is the Market Cap of Xilio Development Inc?

The market capitalization of Xilio Development Inc (XLO) is $40.27M

What is Xilio Development Inc's stock symbol?

The stock symbol (or ticker) of Xilio Development Inc is XLO

How Can Investors Use Xilio Development Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Xilio Development Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Xilio Development Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Xilio Development Inc shares for Indian investors?

When investing in Xilio Development Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Xilio Development Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Xilio Development Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Xilio Development Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Xilio Development Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top